NewLimit

formerly New Limit

Extending human healthspan.

South San Francisco, United States · Founded 2022 · $865.0M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$865.0M
Last Round
$435.0M Venture RoundJun 2026
Rounds
8

About

NewLimit is inventing medicines to restore youthful function in old cells by reprogramming the epigenome. We leverage technologies like single cell genomics, machine learning, and high-throughput functional assays to reveal epigenetic features of aging and discover rejuvenating interventions. Our first programs target the aging liver, immune, and vascular systems as stepping stones to significantly extending human healthspan.

Summary

NewLimit is a Biotech company based in South San Francisco, United States, founded in 2022. It has raised $865.0M in total across 8 rounds, most recently a $435.0M Venture Round round in Jun 2026. Investors include Kleiner Perkins, Founders Fund and Eli Lilly.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundClinical Trial FinancingJun 2026
$435.0M

Sign up to see all 8 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NewLimit on Indexed.vc
<a href="https://indexed.vc/companies/newlimit"><img src="https://indexed.vc/api/badge/company/newlimit" alt="NewLimit on Indexed.vc" width="260" height="76" /></a>